Trial intelligence / Profile preview

T4-T3 Combination vs T4 Monotherapy in Hypothyroidism

NCT00531713Phase 4Completed

Sponsor
Rigshospitalet
Start
Apr 2003
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of liothyronine in hypothyroidism (2 arms), sponsored by Rigshospitalet. Primary endpoints: Short Form-36 Health Survey at 3 months, Symptom Checklist-90-Revised at 3 months and 1 more. Started Apr 2003; status: completed.

02

Drugs

liothyronine
03

Conditions

hypothyroidism

Beyond the preview

Go deeper on NCT00531713.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00531713.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call